The briefing
Northwestern University researchers report in Nature that a new immunotherapy strategy shows promise against one of the most aggressive and deadly brain cancers. The findings suggest potential therapeutic benefit but will require further study and clinical validation.
Original headline
Immunotherapy Strategy Shows Promise for Deadly Brain Cancer